Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Paul Conley
AddedMar 31, 2024
UpdatedJun 28, 2026
Paul Conley

Paul Conley

Founder & CEO, General Inception

CrunchbaseLinkedIn

Paul Conley's Career

General Inception
General Inception

San Francisco, CA, US

Founder & CEO· C-Suite · Management
Twist Bioscience
Twist Bioscience

San Francisco, CA, US

Board Member· Board
10x Genomics
10x Genomics

Pleasanton, CA, US

Board Member· Board
HealthTell
HealthTell

San Ramon, CA, US

Board Member· Board
Menlo Microsystems
Menlo Microsystems

Irvine, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Paul Conley's Career

General Inception
General Inception
Investment FirmInvestment Firm442020San Francisco, CA, US
Founder & CEO· C-Suite · Management
Twist Bioscience
Twist Bioscience
Public$553.1M9892013San Francisco, CA, US
Board Member· Board

Leadership at Twist Bioscience

Bill BanyaiBill BanyaiBoard Member
Bob RagusaBob RagusaBoard Member
Emily LeproustEmily LeproustBoard Member
Rob ChessRob ChessBoard Member
Xiaoying MaiXiaoying MaiBoard Member
Keith CrandellKeith CrandellBoard Member

Similar to Twist Bioscience

Switchback SystemsSwitchback SystemsSan Francisco, CA, USDNA Synthesisest. 2019Switchback SystemsSan Francisco, CA, US · est. 2019

Switchback Systems, a San Francisco-based software startup, specializes in efficient, scalable DNA synthesis platforms.

Seed · $7.1M14
Ansa BiotechnologiesAnsa BiotechnologiesEmeryville, CA, USDNA Synthesisest. 2018Ansa BiotechnologiesEmeryville, CA, US · est. 2018

Ansa Biotechnologies: Pioneering enzyme-based, efficient DNA synthesis.

Series A · $83.4M82
SynthegoSynthegoRedwood City, CA, USCrispr Kits, Gene Editingest. 2012SynthegoRedwood City, CA, US · est. 2012

US-based Synthego Corp. provides software solutions for biological research, primarily serving California.

Series E · $460.5M322
10x Genomics
10x Genomics
Public$242.6M4482012Pleasanton, CA, US
Board Member· Board

Recent news

Genetics testing startup Nucleus Genomics criticized for its embryo product: ‘Makes me so nauseous’Startups | TechCrunch · 2025
Promise Bio exits stealth backed by Pfizer and AstraZenecaTechCrunch · 2024

Leadership at 10x Genomics

Ben HindsonBen HindsonBoard Member
Bryan RobertsBryan RobertsBoard Member
Shehnaaz SulimanShehnaaz SulimanBoard Member
Sri KosarajuSri KosarajuBoard Member
John StuelpnagelJohn StuelpnagelBoard Member
Serge SaxonovSerge SaxonovCo-Founder

Similar to 10x Genomics

Singular GenomicsSingular GenomicsSan Diego, CA, USGenomic Technologiesest. 2016Singular GenomicsSan Diego, CA, US · est. 2016

Singular Genomics: A dynamic, fast-paced biotech company in California, innovating in genomic technologies.

Public · $176M134
Spatial GenomicsSpatial GenomicsPasadena, CA, USGenomic Analysisest. 2016Spatial GenomicsPasadena, CA, US · est. 2016

Pioneering spatial analysis and comprehensive single-cell assay in intact cells and tissues.

Series A · $56M24
HealthTell
HealthTell
Series B$44.8M1252012San Ramon, CA, US
Board Member· Board

Leadership at HealthTell

Carolyn ComptonCarolyn ComptonBoard Member
Neal WoodburyNeal WoodburyFounder
Caren MasonCaren MasonBoard Member

Similar to HealthTell

HealthSnapHealthSnapMiami, FL, USDisease Management, Patient Monitoringest. 2015HealthSnapMiami, FL, US · est. 2015

HealthSnap: Remote patient monitoring for effective virtual chronic disease management.

Series A · $21.6M75
Heads Up HealthHeads Up HealthScottsdale, AZ, USAnalytics, Health Dataest. 2014Heads Up HealthScottsdale, AZ, US · est. 2014

Data analytics platform providing customizable health dashboards for individuals and healthcare professionals.

Seed · $3.1M42
iHealth LabsiHealth LabsSunnyvale, CA, USHealthcareest. 2010iHealth LabsSunnyvale, CA, US · est. 2010

iHealth: Cloud-based personal healthcare products for proactive health management.

Series A · $25M146
HealthlaneHealthlaneLagos, Lagos, NGHealthcare, Wellnessest. 2019HealthlaneLagos, Lagos, NG · est. 2019

Healthlane: Affordable, preventive healthcare services and data management in Africa.

Angel · $5M22
Menlo Microsystems
Menlo Microsystems
Series C$227.5M1752016Irvine, CA, US
Board Member· Board

Leadership at Menlo Microsystems

Chris GiovannielloChris GiovannielloCo-Founder
Chris KeimelChris KeimelCo-Founder
Marianne WuMarianne WuBoard Member
Russ GarciaRuss GarciaCEO
Rob ReaganRob ReaganCo-Founder

Similar to Menlo Microsystems

Menlo TechnologiesMenlo TechnologiesSanta Clara, CA, USCloud, Mobileest. 2010Menlo TechnologiesSanta Clara, CA, US · est. 2010

Menlo Technologies: A global leader in cloud integration, data analytics, and mobile technology solutions.

129
MicrofabricaMicrofabricaLos Angeles, CA, USMicro Devicesest. 1999MicrofabricaLos Angeles, CA, US · est. 1999

Microfabrica, Inc.: Precision micro-device manufacturer and fabricator serving US markets.

Seed · $65.2M75
Arrow ElectronicsArrow ElectronicsCentennial, CO, USDistribution, Electronicsest. 1935Arrow ElectronicsCentennial, CO, US · est. 1935

Arrow Electronics, a Fortune 500 US firm, specializes in distributing electronic components and computer products.

Public22k

Paul Conley's Co-Investors

Jacob BecraftJacob BecraftCo-invested · Infinimmune SeedJoshua MeierJoshua MeierCo-invested · Infinimmune SeedRon AlfaRon AlfaCo-invested · Infinimmune SeedBenjamin KimBenjamin KimCo-invested · Infinimmune Seed

Paul Conley's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · Dunamu

People Similar to Paul Conley

Rob BallRob BallFounder & CEO · Magnesium Development CompanyAlan AubreyAlan AubreyCEO · Top Technology VenturesDror BermanDror BermanBoard Member · Team8Hemant TanejaHemant TanejaUnknown · StripeMatthew HarriganMatthew HarriganCo-Founder · Grand Central Tech